Published Online
on June 21, 2004

A more recent version of this article appeared on July 6, 2004

This Article Full Text (PDF) All Versions of this Article: 110/1/91    most recent 01.CIR.0000133384.38551.A8v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kouroedov, A. Articles by Cosentino, F. Search for Related Content PubMed PubMed Citation Articles by Kouroedov, A. Articles by Cosentino, F. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB 12-O-TETRADECANOYLPHORBOL-13-ACETATE GLUCOSE Related Collections Cardiovascular Pharmacology Other diabetes Other Vascular biology

Submitted on December 11, 2003
Revised on March 30, 2004
Accepted on April 2, 2004

Selective Inhibition of Protein Kinase C₂ Prevents Acute Effects of High Glucose on Vascular Cell Adhesion Molecule-1 Expression in Human Endothelial Cells

Alexei Kouroedov MD, Masato Eto MD, PhD, Hana Joch , Massimo Volpe MD, Thomas F. Lüscher MD, and Francesco Cosentino MD, PhD^*

From Cardiovascular Research, Institute of Physiology, University of Zürich and Cardiovascular Center, University Hospital, Zürich, Switzerland (A.K., M.E., H.J., T.F.L., F.C.); and the Division of Cardiology, 2nd Faculty of Medicine, University La Sapienza, Rome, and IRCCS Neuromed, Pozzilli, Italy (M.V., F.C.).

^* To whom correspondence should be addressed. E-mail: f_cosentino{at}hotmail.com.

Background--Enhanced expression of adhesion molecules by the endothelium may account for vascular damage in diabetics and nondiabetic patients who develop stress hyperglycemia during acute myocardial infarction. We analyzed the phosphorylation of protein kinase C₂ (PKC₂) at serine/threonine residues, which may contribute to the endothelial dysfunction during acute hyperglycemia. Furthermore, this study was designed to investigate whether selective blockade of this regulatory mechanism may prevent the development of endothelial hyperadhesiveness.

Methods and Results--Incubation of the human aortic endothelial cells with high glucose (22.2 mmol/L) resulted in significant increase of vascular cell adhesion molecule (VCAM)-1 protein expression (172±15% versus control; P<0.01). Phorbol 12-myristate 13-acetate, a potent activator of PKC, mimicked the effect of high glucose on VCAM-1 expression. High glucose led to a rapid increase (181±22% versus control; P<0.01) of membrane-bound PKC, reflecting activation of this enzyme. The nonselective inhibitor of PKC₁ and PKC₂ isoforms LY379196, as well as CGP53353, a highly selective inhibitor of PKC₂, prevented in a dose-dependent manner upregulation of VCAM-1. Incubation with high glucose was associated with increased PKC₂ phosphorylation at the Ser-660 residue, and both LY379196 and CGP53353 prevented this event. Exposure of the cells to high glucose also reduced the protein level of the inhibitory subunit of nuclear factor-B, IB, leading to its enhanced binding activity. Selective inhibition of PKC abolished IB degradation.

Conclusions--Our findings demonstrate for the first time that phosphorylation of Ser-660 represents a selective regulatory mechanism for glucose-induced upregulation of VCAM-1. Therefore, PKC₂-selective inhibitors may be promising drugs for treatment of endothelial dysfunction during acute hyperglycemia and possibly in diabetes.

Key words: diabetes mellitus • cell adhesion molecules • endothelium • inhibitors

This article has been cited by other articles:

				E. Osto, A. Kouroedov, P. Mocharla, A. Akhmedov, C. Besler, L. Rohrer, A. von Eckardstein, S. Iliceto, M. Volpe, T. F. Luscher, et al. Inhibition of Protein Kinase C{beta} Prevents Foam Cell Formation by Reducing Scavenger Receptor A Expression in Human Macrophages Circulation, November 18, 2008; 118(21): 2174 - 2182. [Abstract] [Full Text] [PDF]

				T. F. Luscher and J. Steffel Sweet and Sour: Unraveling Diabetic Vascular Disease Circ. Res., January 4, 2008; 102(1): 9 - 11. [Full Text] [PDF]

				M. A. Borger, P. M. Murphy, A. Alam, S. Fazel, M. Maganti, S. Armstrong, V. Rao, and T. E. David Initial results of the chordal-cutting operation for ischemic mitral regurgitation J. Thorac. Cardiovasc. Surg., June 1, 2007; 133(6): 1483 - 1492. [Abstract] [Full Text] [PDF]

				M. Fukuoka, M. Nonaka, S. Masuyama, T. Shimamoto, K. Tambara, H. Yoshida, T. Ikeda, and M. Komeda Chordal "translocation" for functional mitral regurgitation with severe valve tenting: An effort to preserve left ventricular structure and function J. Thorac. Cardiovasc. Surg., April 1, 2007; 133(4): 1004 - 1011. [Abstract] [Full Text] [PDF]

				J. E. Kanter, F. Johansson, R. C. LeBoeuf, and K. E. Bornfeldt Do Glucose and Lipids Exert Independent Effects on Atherosclerotic Lesion Initiation or Progression to Advanced Plaques? Circ. Res., March 30, 2007; 100(6): 769 - 781. [Abstract] [Full Text] [PDF]

				A. Kawakami, M. Aikawa, P. Alcaide, F. W. Luscinskas, P. Libby, and F. M. Sacks Apolipoprotein CIII Induces Expression of Vascular Cell Adhesion Molecule-1 in Vascular Endothelial Cells and Increases Adhesion of Monocytic Cells Circulation, August 15, 2006; 114(7): 681 - 687. [Abstract] [Full Text] [PDF]

				L. Gao, F. Wang, B. Wang, B. Gong, J. Zhang, X. Zhang, and J. Zhao Cilostazol Protects Diabetic Rats from Vascular Inflammation via Nuclear Factor-{kappa}B-Dependent Down-Regulation of Vascular Cell Adhesion Molecule-1 Expression J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 53 - 58. [Abstract] [Full Text] [PDF]

				C. Vecchione, A. Aretini, G. Marino, U. Bettarini, R. Poulet, A. Maffei, M. Sbroggio, L. Pastore, M. T. Gentile, A. Notte, et al. Selective Rac-1 Inhibition Protects From Diabetes-Induced Vascular Injury Circ. Res., February 3, 2006; 98(2): 218 - 225. [Abstract] [Full Text] [PDF]

				R. De Caterina, A. Zampolli, S. Del Turco, R. Madonna, and M. Massaro Nutritional mechanisms that influence cardiovascular disease Am. J. Clinical Nutrition, February 1, 2006; 83(2): 421S - 426S. [Abstract] [Full Text] [PDF]

				S.-Q. Wu and W. C. Aird Thrombin, TNF-{alpha}, and LPS exert overlapping but nonidentical effects on gene expression in endothelial cells and vascular smooth muscle cells Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H873 - H885. [Abstract] [Full Text] [PDF]

				Y. Rikitake and J. K. Liao Rho-Kinase Mediates Hyperglycemia-Induced Plasminogen Activator Inhibitor-1 Expression in Vascular Endothelial Cells Circulation, June 21, 2005; 111(24): 3261 - 3268. [Abstract] [Full Text] [PDF]

				C. Rask-Madsen and G. L. King Proatherosclerotic Mechanisms Involving Protein Kinase C in Diabetes and Insulin Resistance Arterioscler. Thromb. Vasc. Biol., March 1, 2005; 25(3): 487 - 496. [Abstract] [Full Text] [PDF]

				Z. He and G. L. King Protein Kinase C{beta} Isoform Inhibitors: A New Treatment for Diabetic Cardiovascular Diseases Circulation, July 6, 2004; 110(1): 7 - 9. [Full Text] [PDF]